FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Toth Christopher A. 2. Issuer Name and Ticker or Trading Symbol VARIAN MEDICAL SYSTEMS INC [ VAR ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
SVP and Pres. Oncology Systems
(Last)         (First)         (Middle)
C/O VARIAN MEDICAL SYSTEMS, INC., 3100 HANSEN WAY M/S E327
3. Date of Earliest Transaction (MM/DD/YYYY)
12/1/2020
(Street)
PALO ALTO, CA 94304
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  12/1/2020    M    4823  A $80.40  7694  D   
Common Stock  12/1/2020    F    3514 (1) D $174.19  4180  D   
Common Stock  12/1/2020    M    8794  A $112.82  12974  D   
Common Stock  12/1/2020    F    7232 (2) D $174.19  5742  D   
Common Stock  12/1/2020    M    8573  A $131.77  14315  D   
Common Stock  12/1/2020    F    7521 (3) D $174.19  6794  D   
Common Stock  12/1/2020    M    13450  A $146.91  20244  D   
Common Stock  12/1/2020    F    12388 (4) D $174.19  7856  D   
Common Stock  12/1/2020    M    11594  A $0  19450  D   
Common Stock  12/1/2020    F    5748 (5) D $174.19  13702  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non Qualified Stock Option (Right to Buy)  $80.40  12/1/2020    M        4823    (6) 2/10/2024  Common Stock  4823  $0  0  D   
Non Qualified Stock Option (Right to Buy)  $112.82  12/1/2020    M        8794    (7) 2/8/2025  Common Stock  8794  $0  0  D   
Non Qualified Stock Option (Right to Buy)  $131.77  12/1/2020    M        8573    (8) 2/14/2026  Common Stock  8573  $0  0  D   
Non Qualified Stock Option (Right to Buy)  $146.91  12/1/2020    M        13450    (9) 2/13/2027  Common Stock  13450  $0  0  D   
Restricted Stock Units   (10) 12/1/2020    M        11594    (11)  (11) Common Stock  11594  $0  4825  D   

Explanation of Responses:
(1)  Represents shares withheld for payment of exercise price of $80.40 per share as well as payment of federal, state and payroll taxes due on settlement
(2)  Represents shares withheld for payment of exercise price of $112.82 per share as well as payment of federal, state and payroll taxes due on settlement.
(3)  Represents shares withheld for payment of exercise price of $131.77 per share as well as payment of federal, state and payroll taxes due on settlement
(4)  Represents shares withheld for payment of exercise price of $146.91 per share as well as payment of federal, state and payroll taxes due on settlement
(5)  Represents shares withheld from vested RSUs for the payment of federal, state and payroll taxes due on settlement.
(6)  Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(7)  Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(8)  Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(9)  Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The options originally vested as follows: one third on February 13, 2021, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(10)  Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
(11)  Per agreement executed on 24 November 2020, vesting on all outstanding restricted stock unit shares has been accelerated. The restricted stock units vest originally vested in three equal installments on August 10, 2021, August 10, 2022, and August 10, 2023.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Toth Christopher A.
C/O VARIAN MEDICAL SYSTEMS, INC.
3100 HANSEN WAY M/S E327
PALO ALTO, CA 94304


SVP and Pres. Oncology Systems

Signatures
/s/ Michael B. Dunn , attorney-in-fact for Christopher A. Toth 12/1/2020
**Signature of Reporting Person Date